Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Accounting Officer

President & COO

Pres&Chief Investment Officer

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inf...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-28	Premium	sold (taxes)	Premium	Premium	Premium	CFO
2024-04-24	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-04-24	Premium	acquired	Premium	Premium	Premium	-
2024-04-24	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-04-24	Premium	acquired	Premium	Premium	Premium	-
2024-04-24	Premium	acquired	Premium	Premium	Premium	-
2024-04-24	Premium	acquired	Premium	Premium	Premium	-
2024-04-24	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-04-24	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-04-22	Premium	acquired	Premium	Premium	Premium	CFO
2024-04-22	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-04-20	Premium	sold (taxes)	Premium	Premium	Premium	President & COO
2024-04-20	Premium	sold (taxes)	Premium	Premium	Premium	CFO
2024-04-20	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-04-20	Premium	sold (taxes)	Premium	Premium	Premium	CEO
2024-03-30	Premium	sold (taxes)	Premium	Premium	Premium	Pres&Chief Investment Officer
2024-03-30	Premium	acquired	Premium	Premium	Premium	Pres&Chief Investment Officer
2024-03-30	Premium	sold (taxes)	Premium	Premium	Premium	CEO
2024-03-30	Premium	acquired	Premium	Premium	Premium	CEO
2024-03-28	Premium	sold (taxes)	Premium	Premium	Premium	CFO
2024-03-20	Premium	sold (taxes)	Premium	Premium	Premium	President & COO
2024-03-20	Premium	sold (taxes)	Premium	Premium	Premium	CEO
2024-03-20	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-03-07	Premium	sold	Premium	Premium	Premium	-
2024-03-07	Premium	sold	Premium	Premium	Premium	-

ROIV - Roivant Sciences Ltd. Stock Price, Fair Value and News

Latest Insider Trading transactions for ROIV